SCHEMBL15528596

SCHEMBL15528596

Cc1cccc2cc(OC(F)F)n(C(=O)O)c12

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PLA2G10 O15496 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ATM Q13315 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.32
TSHR P16473 1/20 0.32
FFAR1 O14842 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
TAS2R14 Q9NYV8 1/20 0.31
MRGPRX4 Q96LA9 1/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
PDE2A O00408 1/20 0.31
PDE10A Q9Y233 1/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
KDM4E B2RXH2 1/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15528336 0.82 PLA2G10 (0.36) PLA2G10SMN1; SMN2GAAMAPTTSHR
SCHEMBL29148947 0.71 ALDH1A1 (0.40) PLA2G10ATMGAAL3MBTL1MEN1
SCHEMBL28550759 0.67 MCL1 (0.44) PLA2G10GAAMAPTTSHRKDM4E
SCHEMBL29149059 0.66 NR1H2 (0.41)
SCHEMBL30988680 0.64 THRA (0.37) SMN1; SMN2ATMGAAMAPTTSHR
SCHEMBL30419255 0.63 PLA2G10 (0.50) PLA2G10
SCHEMBL31462830 0.63 NR1H2 (0.43) MEN1KMT2A
SCHEMBL2490611 0.62 OXER1 (0.40) SMN1; SMN2MAPTL3MBTL1MEN1KMT2A
SCHEMBL10233030 0.62 MCL1 (0.57) PLA2G10SMN1; SMN2GAAMAPTTSHR
SCHEMBL12569955 0.62 ALDH1A1 (0.60) ATMMAPTTAS2R14L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2855456-A1 COMPLEMENT PATHWAY MODULATORS AND USES THEREOF Novartis AG (CH) 2015-04-08 EP disclosed
WO-2013164802-A1 COMPLEMENT PATHWAY MODULATORS AND USES THEREOF NOVARTIS AG (CH) 2013-11-07 WO disclosed